Orforglipron
Stock Recap #PipelineProspector

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

November saw several big ticket acquisitions across the consumer health and biopharma space, includ

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

October was abuzz with dealmaking. Pharma majors such as Novartis, Novo Nordisk, and Bristol Myers

Pipeline Prospector April 2025: Merck KGaA buys SpringWorks for US$ 3.9 bn; Swiss giants lead pharma migration to US soil

April witnessed considerable volatility in pharmaceutical stocks as the US President Donald Trump&rs